Wolverine Trading
MED icon

Wolverine Trading’s Medifast MED Stock Holding History

Wolverine Trading’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-67,100
Closed -$928K – 5256
2025
Q1 		$928K Buy
67,100
+44,400
+196% +$667K ﹤0.01% 2310
2024
Q4 		$404K Sell
22,700
-11,900
-34% -$221K ﹤0.01% 3655
2024
Q3 		$666K Sell
34,600
-5,500
-14% -$106K ﹤0.01% 2764
2024
Q2 		$875K Buy
+40,100
New +$1.07M ﹤0.01% 2321
2023
Q4 		– Sell
-5,700
Closed -$427K – 4919
2023
Q3 		$427K Buy
+5,700
New +$506K ﹤0.01% 2918
2023
Q2 		– Sell
-3,100
Closed -$306K – 4652
2023
Q1 		$306K Buy
+3,100
New +$344K ﹤0.01% 2989
2022
Q3 		– Sell
-3,000
Closed -$549K – 5035
2022
Q2 		$549K Buy
3,000
+700
+30% +$125K ﹤0.01% 2450
2022
Q1 		$393K Buy
2,300
+1,200
+109% +$226K ﹤0.01% 3552
2021
Q4 		$232K Sell
1,100
-400
-27% -$82.7K ﹤0.01% 4494
2021
Q3 		$298K Sell
1,500
-600
-29% -$147K ﹤0.01% 4717
2021
Q2 		$586K Buy
+2,100
New +$569K ﹤0.01% 3455
2021
Q1 		– Sell
-2,300
Closed -$444K – 6197
2020
Q4 		$444K Buy
+2,300
New +$406K ﹤0.01% 3303
2019
Q3 		– Sell
-22,000
Closed -$2.82M – 4763
2019
Q2 		$2.82M Buy
22,000
+13,100
+147% +$1.82M 0.01% 1283
2019
Q1 		$1.14M Sell
8,900
-22,800
-72% -$2.89M ﹤0.01% 1956
2018
Q4 		$3.94M Sell
31,700
-18,100
-36% -$3.1M 0.01% 961
2018
Q3 		$11M Buy
49,800
+38,200
+329% +$7.74M 0.02% 516
2018
Q2 		$1.08M Hold
11,600
– – ﹤0.01% 2186
2018
Q1 		$1.08M Buy
11,600
+8,300
+252% +$620K ﹤0.01% 2186
2017
Q4 		$230K Sell
3,300
-10,000
-75% -$663K ﹤0.01% 3968
2017
Q3 		$790K Buy
+13,300
New +$662K ﹤0.01% 2115

Other funds holding MED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wolverine Trading's MED Position: Q2 2025 in Review

Wolverine Trading sold out of Medifast (MED) in Q2 2025, closing a stake of 13,044 shares — an estimated $180K sold.

Wolverine Trading first reported a position in MED in Q4 2017 and held it in 13 quarters. The position peaked at $2.31M in Q2 2019. 120 funds tracked by Wall St. Rank hold MED as of Q2 2025.

  • Wolverine Trading reported no remaining Medifast position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 13,044 Medifast shares in Q2 2025, an estimated $180K.
  • Wolverine Trading first reported a position in Medifast in Q4 2017 and held it in 13 quarters.
  • Wolverine Trading's Medifast position peaked at $2.31M in Q2 2019.
  • 120 funds tracked by Wall St. Rank held Medifast as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.